Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles-Reference-Cited by-同舟云学术

Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles

Published:2016-04 Issue:1 Volume:141 Page:49-56
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Murakami Ryusuke,Matsumura Noriomi,Brown J.B.,Wang Zhipeng,Yamaguchi Ken,Abiko Kaoru,Yoshioka Yumiko,Hamanishi Junzo,Baba Tsukasa,Koshiyama Masafumi^ORCID,Mandai Masaki,Yamada Ryo,Konishi Ikuo

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results;Piccart;J. Natl. Cancer Inst.,2000

2. Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer;Markman;Gynecol. Oncol.,2013

3. Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials;Schwaederle;J. Clin. Oncol.,2015

4. PARP inhibitors in ovarian cancer: current status and future promise;Liu;Gynecol. Oncol.,2014

5. Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data;Bosquet;Cancer Res.,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer;The American Journal of Pathology;2024-07

2. Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer;International Journal of Clinical Oncology;2024-06-12

3. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models;International Journal of Clinical Oncology;2024-05-20

4. Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review);Tumors of female reproductive system;2024-05-18

5. Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma;Virchows Archiv;2024-04-16